.gif)
NeuroMetrix, Inc. announced that Quell® Wearable Pain Relief Technology™ will be featured for the second year in a row at the American Society for Regional Anesthesia's Annual Pain Medicine Meeting to be held November 17-19 in San Diego, CA.
"Since we introduced Quell to the ASRA community a year ago, we have made significant progress against our healthcare professional strategy," said Shai N. Gozani, M.D., Ph.D., President and Chief Executive Officer of NeuroMetrix. "In the past 12 months, NeuroMetrix has captured over 2,000,000 hours of user data in the Quell Health Cloud, published results in the Journal of Pain Research, and initiated several clinical evaluations that we are excited to discuss with this year's meeting attendees."
ASRA's Annual Pain Medicine Meeting will bring together over 1,000 clinical practitioners and researchers in the area of pain medicine.
Quell is designed for millions of people suffering from chronic pain. The advanced wearable device is lightweight and can be worn during the day while active, and at night while sleeping. It has been cleared by the FDA for treatment of chronic pain without a prescription. In a recent study, 81% of Quell users reported an improvement in their chronic pain. Quell users can start, stop, and adjust therapy discreetly via the optional Quell Relief app. Quell also offers advanced sleep tracking that provides feedback on eight dimensions of sleep including sleep duration, quality, body position, time out of bed, and repetitive leg movements throughout the night. Quell was the winner of the 2016 SXSW (South by Southwest) Innovation Award for Best Wearable Technology. Quell is available at select healthcare professionals and retailers.
